Cart
sales@molnova.com
AM6545
CAS No. 1245626-05-4
AM6545( —— )
Catalog No. M33829 CAS No. 1245626-05-4
AM6545 is a selective and potent peripheral restricted cannabinoid receptor 1 (CB1) antagonist that inhibits the CB2 receptor, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate-induced obese mice, and may be useful in the study of obesity and diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 135 | Get Quote |
|
| 5MG | 204 | Get Quote |
|
| 10MG | 302 | Get Quote |
|
| 25MG | 664 | Get Quote |
|
| 50MG | 907 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAM6545
-
NoteResearch use only, not for human use.
-
Brief DescriptionAM6545 is a selective and potent peripheral restricted cannabinoid receptor 1 (CB1) antagonist that inhibits the CB2 receptor, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate-induced obese mice, and may be useful in the study of obesity and diabetes.
-
DescriptionAM6545 is a peripherally active, cannabinoid receptor antagonist with limited brain penetration. AM6545 binds to CB1 and CB2 receptors with Kis of 1.7 nM and 523 nM, respectively. AM6545 is a neutral antagonist. AM6545 can be used for the research of obesity and its complications.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1245626-05-4
-
Formula Weight556.46
-
Molecular FormulaC26H23Cl2N5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN#CCCC#CC=1C=CC(=CC1)C2=C(C(=NN2C3=CC=C(Cl)C=C3Cl)C(=O)NN4CCS(=O)(=O)CC4)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. N L Cluny, et al. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol. 2010 Oct;161(3):629-42.?
molnova catalog
related products
-
N-Oleoyl glycine
N-Oleoyl glycine, a lipoamino acid, was able to promote 3T3-L1 adipogenesis through the activation of CB1 receptor and the enhancement of insulin-mediated Akt signaling pathway.
-
JTE907
A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively.
-
ML-193
ML-193 is a potent and selective GPR55 antagonist( IC50 : 221 nM).
